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Although most patients survive an acute coronary syndrome [ACS myocardial infarction
(MI) or unstable angina (UA)], within 5 years 22% will be re-hospitalized and more than 1
in 3 will die.1 Thus, identifying modifiable risk factors for ACS recurrence and mortality is
critical.
Short sleep duration (less than 7 hours per night), is associated with a range of physiologic
responses (eg, inflammation, impaired glucose tolerance, reduced insulin sensitivity, and
appetite regulation), health behaviors, and comorbidities (eg, poor diet, diabetes, metabolic
syndrome, obesity, and hypertension) that increase risk of coronary heart disease (CHD).2-6
A meta-analysis of prospective cohort studies found that self-reported short sleep was
associated with a 48% increased risk of incident CHD.5 Short sleep is also common among
post-ACS patients.7,8 However, no study has examined whether short sleep is associated
with risk in ACS patients. We hypothesized that ACS patients who report short sleep
duration in the month after ACS would be at increased risk for 1-year ACS recurrence and
mortality relative to those who report sleeping 7 hours or more per night.
Methods
Consecutively hospitalized patients with ACS were enrolled between February 1, 2009, and
March 31, 2012, in the single-site, prospective, observational cohort Prescription Use,
Lifestyle and Stress Evaluation (PULSE) study (N = 866). Participants completed the
Pittsburgh Sleep Quality Index (PSQI),9 a widely used self-report measure of sleep during
the past month. Responses to the item, “During the past month, how many hours of actual
sleep did you get at night?,” were dichotomized as less than 7 hours (short sleep) or 7 hours
or more.5 The primary composite endpoint was first ACS recurrence (hospitalization for
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nonfatal MI or unstable angina) or death within 1-year of their index ACS hospitalization.
Patient-reported re-hospitalizations were adjudicated from hospital records by board-
certified cardiologists. The Social Security National Death Index was searched to verify vital
status.
Cox proportional hazards regression models were used to determine the association of short
sleep with 1-year ACS recurrence or mortality. Model 1 estimated the unadjusted
association between short sleep and the composite outcome. Model 2 included additional
adjustment for self-reported age, sex, race, years of education, left ventricular ejection
fraction (LVEF) less than 40% (abstracted from the medical record), Charlson comorbidity
index, and Global Registry of Acute Coronary Events (GRACE) risk score. Model 3 further
adjusted for baseline depressive symptoms, body mass index (BMI), past-month sleep
medications use, past-month breathing-related sleep disturbance, and perceived sleep quality
(measured with the PSQI).
Participants who experienced ACS recurrence or death before 1 month (n=8) and those with
incomplete data (n=116) were excluded. Parameter estimates using multiply imputed data
did not differ appreciably from complete data estimates. Complete data were available for
742 patients.
Results
Participants who reported short sleep were significantly younger, were more likely to be
women, had lower GRACE risk scores, reported higher depressive symptoms, and were
more likely to report past-month use of sleep medications and past-month breathing-related
sleep disturbances than their counterparts with longer sleep (Table 1). Overall, 127
participants had a primary end point (31 MI cases, 78 UA cases, and 18 deaths) during 1-
year follow-up. In this sample, 76 participants (20.1%) who reported short sleep had a
primary end point compared with 51 (14.0%) who reported at least 7 hours of sleep.
Short sleep was associated with an increased 1-year risk of ACS recurrence or mortality in
the unadjusted model (hazard ratio [HR]=1.52; 95% CI, 1.06-2.17) and remained significant
after adjustment for demographics and clinical disease severity (HR=1.50; 95% CI,
1.05-2.16) (Figure). Black race (HR=1.96; 95% CI, 1.32-2.89) and Charlson comorbidity
index (HR=1.22; 95% CI, 1.11-1.34) were the only significant covariates in this model.
Further adjustment for baseline depressive symptoms, BMI, past-month sleep medication
use, and past-month breathing-related sleep disturbances did not alter the association of
short sleep with poor prognosis (HR=1.52; 95% CI, 1.06-2.18). A sensitivity analysis with
further adjustment for perceived subjective sleep quality, measured with the global PSQI
score, did not alter the association (HR=1.60; 95% CI, 1.05-2.44).
Conclusion
Our results suggest that more than half of ACS patients may experience short sleep duration
(sleeping <7 hours per night) in the month after ACS, and that short sleep is associated with
a more than 50% increased risk of ACS recurrence or death in the year after their index ACS
event. The association of short sleep with recurrent ACS and mortality was consistent and
independent of demographics, disease severity, comorbidities, depressive symptoms, BMI,
sleep medication use, and breathing-related sleep disturbances.
Although short sleep has been linked to risk factors for CHD (eg, endothelial dysfunction,
elevated C-reactive protein level, and metabolic dysregulation),5,7 the underlying
pathophysiologic mechanisms and the direction of causality are not yet known. Future
research should identify the biological and psychosocial mechanisms by which short sleep
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confers excess risk of poor prognosis and whether short sleep can be modified to improve
prognosis. For example, short sleep might deplete an individual's self-regulation resources,
which might in turn inhibit an individual's capacity to perform health-promoting behaviors,
which might place him or her at increased risk for ACS recurrence and mortality.10
Our study is not without its limitations. First, we used a self-report measure of sleep
duration. However, unless participants differentially misclassified their sleep duration based
on their risk for recurrence and mortality, error responses would have biased our results
toward no effect for short sleep. Relatedly, we used self-reported breathing-related sleep
disturbances as a proxy for sleep apnea; thus, we were only able to adjust for confounding
due to the presence of sleep-disordered breathing that was known to participants. Second,
we could determine average sleep duration only for the month after the index
hospitalization. In sum, short sleep in the month after ACS appears to confer risk of ACS
recurrence and mortality, independent of likely confounders. Future research should use
prospective designs with objective measures of sleep, and test whether short sleep is
modifiable in ACS patients and whether interventions can offset the risk associated with it.
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Cox proportional hazards regression analysis predicted curve for acute coronary syndrome
(ACS) patients by sleep duration, adjusted for age, sex, race, years of education, Charlson
comorbidity index, Global Registry of Acute Coronary Events risk score, and left ventricular
ejection fraction.
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Table 1
Sociodemographic and Medical Characteristics of Post-ACS Patients by Sleep Duration, PULSE (N = 742)a
Characteristic Sleep ≥7 hours (n = 364) Sleep <7 hours (n = 378) P
Demographics
Age, y 64.62 (11.03) 62.34 (11.60) .006
Female, No. (%) 110 (30.2) 142 (37.6) .04
Educational level, y 13.24 (4.36) 13.20 (4.17) .91
Black, No. (%) 73 (20.1) 91 (24.1) .19
Clinical Severity
Charlson comorbidity index 1.70 (1.69) 1.58 (1.65) .35
GRACE 93.78 (29.09) 89.39 (30.17) .04
LVEF <40%, No. (%) 49 (13.5) 47 (12.4) .68
Behavioral, Psychosocial, and Sleep Factors
Body mass index 28.92 (5.56) 29.61 (5.86) .10
Depressive symptoms 7.33 (6.78) 9.65 (7.11) <.001
Past-month sleep medication use, No. (%) 53 (14.6) 90 (23.9) .001
Past-month breathing-related sleep disturbance, No. (%) 46 (12.7) 91 (24.2) <.001
Outcome
ACS recurrence or death, No. (%) 51 (14.0) 76 (20.1) .03
Days to ACS recurrence or death 351.11 (96.89) 339.08 (107.77) .11
Abbreviations: ACS, acute coronary syndrome; GRACE, Global Registry of Coronary Events; LVEF, left ventricular ejection fraction; PULSE,
Prescription Use, Lifestyle, and Stress Evaluation study.
a
Data are presented as mean (SD) unless otherwise indicated. Sleep duration was assessed at baseline. ACS recurrence includes hospitalization for
nonfatal MI or unstable angina.
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